1. Home
  2. BIAF vs GLBZ Comparison

BIAF vs GLBZ Comparison

Compare BIAF & GLBZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • GLBZ
  • Stock Information
  • Founded
  • BIAF 2014
  • GLBZ 1949
  • Country
  • BIAF United States
  • GLBZ United States
  • Employees
  • BIAF N/A
  • GLBZ N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • GLBZ Major Banks
  • Sector
  • BIAF Health Care
  • GLBZ Finance
  • Exchange
  • BIAF Nasdaq
  • GLBZ Nasdaq
  • Market Cap
  • BIAF 13.0M
  • GLBZ 13.8M
  • IPO Year
  • BIAF 2022
  • GLBZ N/A
  • Fundamental
  • Price
  • BIAF $2.49
  • GLBZ $4.48
  • Analyst Decision
  • BIAF Hold
  • GLBZ
  • Analyst Count
  • BIAF 1
  • GLBZ 0
  • Target Price
  • BIAF N/A
  • GLBZ N/A
  • AVG Volume (30 Days)
  • BIAF 3.3M
  • GLBZ 6.9K
  • Earning Date
  • BIAF 11-13-2025
  • GLBZ 10-29-2025
  • Dividend Yield
  • BIAF N/A
  • GLBZ N/A
  • EPS Growth
  • BIAF N/A
  • GLBZ N/A
  • EPS
  • BIAF N/A
  • GLBZ 0.01
  • Revenue
  • BIAF $7,681,059.00
  • GLBZ $12,483,000.00
  • Revenue This Year
  • BIAF N/A
  • GLBZ N/A
  • Revenue Next Year
  • BIAF $20.04
  • GLBZ N/A
  • P/E Ratio
  • BIAF N/A
  • GLBZ $439.94
  • Revenue Growth
  • BIAF 4.99
  • GLBZ 8.71
  • 52 Week Low
  • BIAF $2.34
  • GLBZ $3.89
  • 52 Week High
  • BIAF $46.53
  • GLBZ $6.99
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 46.54
  • GLBZ 43.72
  • Support Level
  • BIAF $2.43
  • GLBZ $4.71
  • Resistance Level
  • BIAF $3.50
  • GLBZ $4.89
  • Average True Range (ATR)
  • BIAF 0.29
  • GLBZ 0.15
  • MACD
  • BIAF -0.09
  • GLBZ -0.03
  • Stochastic Oscillator
  • BIAF 5.69
  • GLBZ 24.30

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About GLBZ Glen Burnie Bancorp

Glen Burnie Bancorp is a bank holding company for The Bank of Glen Burnie. It offers retail and commercial banking services such as checking, savings, loans, mobile banking, online banking, wire transfer, ACH services, debit cards, automated teller machines, and safe deposit boxes among others. The bank generates its revenue in the form of interest income. All of the revenues are earned within the United States.

Share on Social Networks: